Neuroinflammation and hypertensive cardiac hypertrophy: mechanisms, pathways, and therapeutic perspectives

Area of Science:

• Cardiovascular Medicine
• Neuroscience
• Immunology

Background:

• Hypertensive cardiac hypertrophy is a primary driver of heart failure and cardiovascular morbidity in chronic hypertension.
• Neuroinflammation is increasingly recognized for its critical role in the development and progression of hypertensive cardiac hypertrophy.
• Understanding the neuro-immune-cardiac axis is crucial for developing effective treatments.

Purpose of the Study:

• To provide a comprehensive review of the interplay between neuroinflammation and hypertensive cardiac hypertrophy.
• To elucidate the roles of the sympathetic nervous system (SNS), immune activation, and central nervous system (CNS) dysregulation.
• To explore molecular mechanisms and potential therapeutic strategies targeting neuroinflammation in cardiac remodeling.

Main Methods:

• Literature review integrating preclinical and clinical findings.
• Analysis of the molecular pathways involved in neuroinflammation-induced cardiac remodeling.
• Synthesis of current knowledge on SNS, immune, and CNS involvement.

Main Results:

• Neuroinflammation, driven by SNS, immune, and CNS dysregulation, is a key factor in hypertensive cardiac hypertrophy.
• Specific molecular mechanisms link neuroinflammation to cardiac remodeling processes.
• Modulation of neuroinflammatory pathways presents promising therapeutic avenues.

Conclusions:

• Neuroinflammation is a critical mediator in hypertensive cardiac hypertrophy.
• Targeting neuroinflammatory pathways holds potential for novel therapeutic interventions.
• Further research integrating preclinical and clinical data is needed to optimize these strategies.